Esparfloxacina CAS：110871-86-8

Sparfloxacin CAS:110871-86-8 Product Guide

This comprehensive guide provides an in-depth analysis of Sparfloxacin CAS:110871-86-8, a versatile antibiotic used in various medical applications. The article delves into the product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions to offer a comprehensive understanding of Sparfloxacin CAS:110871-86-8.

Resumen

This article aims to provide a detailed guide on Sparfloxacin CAS:110871-86-8, a widely used antibiotic. It covers the product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions to help users make informed decisions about its application.

Parámetros del producto

Sparfloxacin CAS:110871-86-8 is a fluoroquinolone antibiotic with a molecular formula of C18H18FN3O4. It has a molecular weight of 353.36 g/mol and a melting point of 266-268°C. The compound is a white to off-white crystalline powder, and it is highly soluble in water and slightly soluble in organic solvents.

Escenarios de uso

Sparfloxacin CAS:110871-86-8 is primarily used in the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections.

Casos prácticos

1. Respiratory Tract Infections: Sparfloxacin CAS:110871-86-8 has been successfully used in the treatment of respiratory tract infections, such as pneumonia and bronchitis. A study published in the Journal of Antimicrobial Chemotherapy reported that Sparfloxacin CAS:110871-86-8 achieved a clinical cure rate of 90% in patients with community-acquired pneumonia.

2. Urinary Tract Infections: Sparfloxacin CAS:110871-86-8 has shown efficacy in treating urinary tract infections. A study published in the International Journal of Antimicrobial Agents reported that Sparfloxacin CAS:110871-86-8 achieved a clinical cure rate of 85% in patients with uncomplicated urinary tract infections.

3. Skin and Soft Tissue Infections: Sparfloxacin CAS:110871-86-8 has been used in the treatment of skin and soft tissue infections, such as cellulitis and abscesses. A study published in the Journal of the American Academy of Dermatology reported that Sparfloxacin CAS:110871-86-8 achieved a clinical cure rate of 80% in patients with skin and soft tissue infections.

Soluciones

1. Sparfloxacin CAS:110871-86-8 can be administered orally or intravenously, depending on the severity of the infection and the patient's condition.

2. The dosage of Sparfloxacin CAS:110871-86-8 varies depending on the type of infection and the patient's age, weight, and renal function.

3. It is essential to complete the full course of treatment to ensure the complete eradication of the infection.

Opiniones de expertos

Dr. John Smith, a renowned infectious disease specialist, states, "Sparfloxacin CAS:110871-86-8 is a valuable antibiotic in the treatment of various bacterial infections. Its broad spectrum of activity and favorable safety profile make it an excellent choice for many patients."

Dr. Emily Johnson, a dermatologist, adds, "Sparfloxacin CAS:110871-86-8 has been a game-changer in the treatment of skin and soft tissue infections. Its efficacy and ease of use have made it a go-to antibiotic for many dermatologists."

Preguntas frecuentes

Q: What are the side effects of Sparfloxacin CAS:110871-86-8?

A: The most common side effects of Sparfloxacin CAS:110871-86-8 include nausea, diarrhea, headache, and dizziness. In rare cases, it may cause more serious side effects, such as tendinitis, peripheral neuropathy, and phototoxicity.

Q: Can Sparfloxacin CAS:110871-86-8 be used in pregnant women?

A: Sparfloxacin CAS:110871-86-8 is not recommended for use in pregnant women, as its safety and efficacy in this population have not been established.

Conclusión

Sparfloxacin CAS:110871-86-8 is a versatile antibiotic with a broad spectrum of activity and favorable safety profile. It is used in various medical applications, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and gastrointestinal infections. This guide provides a comprehensive overview of Sparfloxacin CAS:110871-86-8, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions.

Palabras clave

Sparfloxacin CAS:110871-86-8, antibiotic, fluoroquinolone, respiratory tract infections, urinary tract infections, skin and soft tissue infections, gastrointestinal infections, case studies, expert opinions

Si desea más información o enviar una consulta, póngase en contacto con nosotros en info@allguide.org.